FUTIBATINIB

FUTIBATINIB was reported 222 times

FUTIBATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ORAL HERPES ZOSTER 1 0.0455
1 HER2 POSITIVE GASTRIC CANCER 1 0.0312
2 RETROPERITONEAL NEOPLASM METASTATIC 1 0.0303
3 TRICHOMEGALY 1 0.0227
4 ORAL HYPERAESTHESIA 1 0.0222
5 HYPERPHOSPHATAEMIA 36 0.0167
6 PUNCTURE SITE INFECTION 1 0.0161
7 NAIL DEFORMATION 1 0.0149
8 NAIL TOXICITY 4 0.0133
9 LIVER ABLATION 1 0.0132
10 NAIL HYPERTROPHY 2 0.0099
11 MUCOCUTANEOUS TOXICITY 1 0.0095
12 NAIL BED TENDERNESS 1 0.0088
13 ONYCHOLYSIS 13 0.0083
14 VIRAL SKIN INFECTION 1 0.0081
15 ONYCHOMALACIA 1 0.0080
16 FINGERPRINT LOSS 1 0.0062
17 BLOOD PHOSPHORUS INCREASED 16 0.0059
18 CHOLELITHOTOMY 1 0.0046
19 NAIL AVULSION 1 0.0044
20 MOLE EXCISION 1 0.0041
21 ONYCHOMADESIS 17 0.0040
22 NAIL INFECTION 5 0.0035
23 CHOLANGIOCARCINOMA 5 0.0034
24 BREAST CELLULITIS 1 0.0032
25 ONYCHALGIA 3 0.0030
26 ANHIDROSIS 1 0.0025
27 NAIL BED DISORDER 1 0.0023
28 NAIL DISCOLOURATION 9 0.0023
29 FUNGAL FOOT INFECTION 1 0.0023
30 CALCIPHYLAXIS 4 0.0022
31 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
32 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
33 SUBRETINAL FLUID 2 0.0018
34 NAIL DYSTROPHY 1 0.0018
35 PARACENTESIS 1 0.0016
36 BILIARY TRACT INFECTION 1 0.0016
37 CELLULITIS STAPHYLOCOCCAL 1 0.0015
38 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
39 OPHTHALMIC MIGRAINE 1 0.0014
40 GROWTH OF EYELASHES 1 0.0013
41 OVARIAN CANCER METASTATIC 1 0.0012
42 ONYCHOCLASIS 8 0.0012
43 ABDOMINAL LYMPHADENOPATHY 1 0.0012
44 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
45 CATARRH 1 0.0011
46 METASTASES TO ADRENALS 1 0.0011
47 BREAST ABSCESS 1 0.0010
48 WAIST CIRCUMFERENCE INCREASED 1 0.0010
49 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
50 NAIL DISORDER 8 0.0009
51 NAIL GROWTH ABNORMAL 1 0.0009
52 OCULAR TOXICITY 1 0.0009
53 PALMAR ERYTHEMA 1 0.0009
54 MACROCYTOSIS 1 0.0009
55 ORAL MUCOSA EROSION 1 0.0008
56 HYPERAESTHESIA TEETH 1 0.0008
57 CALCIUM DEFICIENCY 1 0.0008
58 BILIARY OBSTRUCTION 1 0.0008
59 OESOPHAGEAL HAEMORRHAGE 1 0.0008
60 HYPERCALCAEMIA 9 0.0007
61 PRESCRIBED UNDERDOSE 14 0.0007
62 PARONYCHIA 3 0.0007
63 ORAL MUCOSAL ERYTHEMA 1 0.0006
64 OPTIC ATROPHY 1 0.0006
65 TONGUE COATED 1 0.0006
66 BLOOD MAGNESIUM DECREASED 5 0.0006
67 SKIN NECROSIS 3 0.0006
68 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
69 SKIN ATROPHY 3 0.0005
70 GINGIVAL RECESSION 1 0.0005
71 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
72 SKIN PAPILLOMA 2 0.0005
73 RADIATION PNEUMONITIS 1 0.0005
74 BLOOD LOSS ANAEMIA 1 0.0004
75 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
76 ESCHERICHIA BACTERAEMIA 1 0.0004
77 SYSTEMIC CANDIDA 1 0.0004
78 METASTASES TO PERITONEUM 1 0.0004
79 TASTE DISORDER 8 0.0004
80 ABDOMINAL INFECTION 1 0.0004
81 RETINAL DISORDER 1 0.0004
82 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
83 EAR CONGESTION 1 0.0004
84 LIP BLISTER 1 0.0004
85 OESOPHAGEAL STENOSIS 1 0.0004
86 HAEMOTHORAX 1 0.0003
87 CYTOPENIA 4 0.0003
88 CHOLANGITIS 2 0.0003
89 DRY EYE 16 0.0003
90 BLOOD CREATININE DECREASED 1 0.0003
91 NASAL DRYNESS 2 0.0003
92 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
93 PEPTIC ULCER 1 0.0003
94 DRY MOUTH 24 0.0003
95 TEMPERATURE INTOLERANCE 3 0.0003
96 METASTASIS 2 0.0003
97 BLOOD PHOSPHORUS DECREASED 1 0.0003
98 PROTEIN TOTAL DECREASED 1 0.0003
99 DISEASE PROGRESSION 31 0.0003
100 GASTRIC INFECTION 1 0.0003
101 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
102 GINGIVAL PAIN 2 0.0003
103 VITAMIN B12 DEFICIENCY 1 0.0002
104 AGEUSIA 6 0.0002
105 ASCITES 7 0.0002
106 POOR PERIPHERAL CIRCULATION 1 0.0002
107 CHAPPED LIPS 1 0.0002
108 BLOOD CALCIUM INCREASED 2 0.0002
109 LIP DRY 2 0.0002
110 PRODUCT DISTRIBUTION ISSUE 2 0.0002
111 STOMATITIS 13 0.0002
112 VITREOUS FLOATERS 2 0.0002
113 ABDOMINAL TENDERNESS 1 0.0002
114 PATHOLOGICAL FRACTURE 1 0.0002
115 AMMONIA INCREASED 1 0.0002
116 HYPERKERATOSIS 1 0.0002
117 ORAL PAIN 4 0.0002
118 ANGIOPATHY 1 0.0002
119 EYE INFECTION 2 0.0002
120 PERIORBITAL SWELLING 1 0.0002
121 ENTEROCOLITIS 1 0.0002
122 HYPERCHLORHYDRIA 1 0.0002
123 NEUROPATHY PERIPHERAL 16 0.0002
124 TOOTH EXTRACTION 2 0.0002
125 BLOOD SODIUM DECREASED 3 0.0002
126 PROCTALGIA 1 0.0002
127 SKIN FISSURES 3 0.0002
128 MUCOSAL INFLAMMATION 4 0.0002
129 HYPOGAMMAGLOBULINAEMIA 1 0.0002
130 METASTASES TO LYMPH NODES 1 0.0001
131 LYMPHOEDEMA 1 0.0001
132 HAIR GROWTH ABNORMAL 1 0.0001
133 HYPERTRANSAMINASAEMIA 1 0.0001
134 MOUTH ULCERATION 3 0.0001
135 LIVER FUNCTION TEST INCREASED 3 0.0001
136 VISUAL FIELD DEFECT 1 0.0001
137 SENSITIVE SKIN 1 0.0001
138 HYPOALBUMINAEMIA 1 0.0001
139 BRAIN FOG 2 0.0001
140 BLOOD ALBUMIN DECREASED 1 0.0001
141 METASTASES TO BONE 2 0.0001
142 METASTASES TO LIVER 2 0.0001
143 PRODUCT COMMUNICATION ISSUE 1 0.0001
144 BLOOD BILIRUBIN INCREASED 3 0.0001
145 RETINAL DETACHMENT 1 0.0001
146 AFFECT LABILITY 1 0.0001
147 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
148 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
149 PRODUCT PHYSICAL ISSUE 2 0.0001
150 HYPOTHERMIA 1 0.0001
151 MOTOR DYSFUNCTION 1 0.0001
152 DEHYDRATION 13 0.0001
153 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
154 DRY SKIN 13 0.0001
155 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
156 PULMONARY THROMBOSIS 1 0.0001
157 TRANSAMINASES INCREASED 2 0.0001
158 MALNUTRITION 1 0.0001
159 NEPHROPATHY TOXIC 1 0.0001
160 MICTURITION URGENCY 1 0.0001
161 INTERNAL HAEMORRHAGE 1 0.0001
162 NEOPLASM 1 0.0001
163 METASTASES TO LUNG 1 0.0001
164 MADAROSIS 1 0.0001
165 ELECTROLYTE IMBALANCE 1 0.0001
166 SPINAL PAIN 1 0.0001
167 BLOOD IRON DECREASED 1 0.0001
168 BACTERAEMIA 1 0.0001
169 THERAPY INTERRUPTED 6 0.0001
170 POLYNEUROPATHY 1 0.0001
171 NOCTURIA 1 0.0001
172 SMALL INTESTINAL OBSTRUCTION 1 0.0001
173 OSTEONECROSIS OF JAW 2 0.0001
174 HAEMATEMESIS 2 0.0001
175 HEPATIC CYTOLYSIS 1 0.0001
176 ALOPECIA 15 0.0001
177 ORAL CANDIDIASIS 1 0.0001
178 TOOTH INFECTION 1 0.0001
179 CONSTIPATION 16 0.0001
180 DIVERTICULITIS 2 0.0001
181 SKIN EXFOLIATION 6 0.0001
182 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
183 SKIN REACTION 1 0.0001
184 LYMPHOPENIA 1 0.0001
185 HYPERSOMNIA 2 0.0001
186 IMPAIRED QUALITY OF LIFE 1 0.0001
187 MYELODYSPLASTIC SYNDROME 1 0.0001
188 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
189 BONE PAIN 4 0.0001
190 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
191 LIVER DISORDER 3 0.0001
192 CATARACT 4 0.0001
193 LACRIMATION INCREASED 2 0.0001
194 HIP ARTHROPLASTY 1 0.0001
195 THYROID DISORDER 1 0.0001
196 MUSCULOSKELETAL CHEST PAIN 1 0.0001
197 DECREASED APPETITE 15 0.0001
198 THERAPY PARTIAL RESPONDER 1 0.0001
199 ULCER 1 0.0001
200 EYE DISORDER 2 0.0001
201 DIARRHOEA 39 0.0001
202 URINARY RETENTION 2 0.0001
203 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
204 NEUROTOXICITY 1 0.0001
205 HEAD DISCOMFORT 1 0.0001
206 GASTROENTERITIS VIRAL 1 0.0001
207 BLOOD GLUCOSE ABNORMAL 1 0.0001
208 HEPATIC CIRRHOSIS 1 0.0001
209 PHOTOPHOBIA 1 0.0001
210 GASTRIC ULCER 1 0.0001
211 MUSCULOSKELETAL DISORDER 1 0.0001
212 ERUCTATION 1 0.0001
213 KIDNEY INFECTION 1 0.0001
214 PLEURAL EFFUSION 3 0.0000
215 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
216 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
217 RENAL IMPAIRMENT 4 0.0000
218 PAIN IN EXTREMITY 14 0.0000
219 MYALGIA 8 0.0000
220 RETCHING 1 0.0000
221 BLOOD CREATININE INCREASED 3 0.0000
222 PRODUCT PRESCRIBING ISSUE 1 0.0000
223 HEPATOTOXICITY 1 0.0000
224 GLOSSODYNIA 1 0.0000
225 HEPATIC ENZYME INCREASED 3 0.0000
226 BURNING SENSATION 3 0.0000
227 LOCALISED INFECTION 1 0.0000
228 INTERSTITIAL LUNG DISEASE 2 0.0000
229 UNDERDOSE 3 0.0000
230 CEREBRAL INFARCTION 1 0.0000
231 LIVER INJURY 1 0.0000
232 ENCEPHALOPATHY 1 0.0000
233 DYSPEPSIA 4 0.0000
234 DYSGEUSIA 3 0.0000
235 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
236 PNEUMONIA ASPIRATION 1 0.0000
237 GASTRIC CANCER 1 0.0000
238 FLUID RETENTION 2 0.0000
239 HAEMOGLOBIN DECREASED 4 0.0000
240 DRUG RESISTANCE 1 0.0000
241 ILLNESS 4 0.0000
242 UNRESPONSIVE TO STIMULI 1 0.0000
243 SKIN ULCER 1 0.0000
244 VOMITING 18 0.0000
245 JOINT STIFFNESS 1 0.0000
246 EAR INFECTION 1 0.0000
247 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
248 ASTHENIA 14 0.0000
249 JAUNDICE 1 0.0000
250 DEATH 32 0.0000
251 FATIGUE 28 0.0000
252 BLISTER 2 0.0000
253 EYE PAIN 2 0.0000
254 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
255 PAIN IN JAW 1 0.0000
256 FLATULENCE 2 0.0000
257 INTENTIONAL DOSE OMISSION 1 0.0000
258 RED BLOOD CELL COUNT DECREASED 1 0.0000
259 HYPOTENSION 7 0.0000
260 HERPES ZOSTER 2 0.0000
261 DYSPHONIA 2 0.0000
262 BLOOD POTASSIUM DECREASED 1 0.0000
263 HEPATIC FAILURE 1 0.0000
264 NAUSEA 26 0.0000
265 OEDEMA PERIPHERAL 4 0.0000
266 EPILEPSY 1 0.0000
267 WEIGHT DECREASED 9 0.0000
268 DRUG-INDUCED LIVER INJURY 1 0.0000
269 CYSTITIS 1 0.0000
270 OSTEONECROSIS 1 0.0000
271 BACK PAIN 7 0.0000
272 VISUAL ACUITY REDUCED 1 0.0000
273 SKIN DISORDER 1 0.0000
274 HAEMATURIA 1 0.0000
275 DELIRIUM 1 0.0000
276 ABDOMINAL DISTENSION 3 0.0000
277 HAEMORRHAGE 3 0.0000
278 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
279 INFECTION 4 0.0000
280 HYPERGLYCAEMIA 1 0.0000
281 PANIC ATTACK 1 0.0000
282 DYSURIA 1 0.0000
283 EYE SWELLING 1 0.0000
284 HEPATIC FUNCTION ABNORMAL 1 0.0000
285 EPISTAXIS 2 0.0000
286 INTESTINAL OBSTRUCTION 1 0.0000
287 ARTHRITIS 2 0.0000
288 NEUTROPHIL COUNT DECREASED 1 0.0000
289 TREMOR 4 0.0000
290 POLLAKIURIA 1 0.0000
291 SEPTIC SHOCK 1 0.0000
292 OFF LABEL USE 20 0.0000
293 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
294 PULMONARY OEDEMA 1 0.0000
295 GASTROINTESTINAL DISORDER 2 0.0000
296 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
297 THROAT IRRITATION 1 0.0000
298 NEPHROLITHIASIS 1 0.0000
299 TINNITUS 1 0.0000
300 HYPOKALAEMIA 1 0.0000
301 RENAL DISORDER 1 0.0000
302 COGNITIVE DISORDER 1 0.0000
303 ARRHYTHMIA 1 0.0000
304 OCULAR HYPERAEMIA 1 0.0000
305 COMA 1 0.0000
306 ANAEMIA 4 0.0000
307 RASH ERYTHEMATOUS 1 0.0000
308 CONTUSION 2 0.0000
309 HYPOGLYCAEMIA 1 0.0000
310 PERIPHERAL SWELLING 3 0.0000
311 ERYTHEMA 4 0.0000
312 ABDOMINAL PAIN UPPER 4 0.0000
313 INFLAMMATION 1 0.0000
314 MUSCULOSKELETAL PAIN 1 0.0000
315 PARAESTHESIA 3 0.0000
316 PANCREATITIS 1 0.0000
317 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
318 INSOMNIA 5 0.0000
319 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
320 OEDEMA 1 0.0000
321 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
322 SEPSIS 2 0.0000
323 NECK PAIN 1 0.0000
324 ABDOMINAL DISCOMFORT 3 0.0000
325 THROMBOCYTOPENIA 2 0.0000
326 OXYGEN SATURATION DECREASED 1 0.0000
327 HYPONATRAEMIA 1 0.0000
328 MUSCULAR WEAKNESS 2 0.0000
329 URINARY TRACT INFECTION 3 0.0000
330 LETHARGY 1 0.0000
331 EYE IRRITATION 1 0.0000
332 SEIZURE 2 0.0000
333 ABDOMINAL PAIN 4 0.0000
334 ARTHRALGIA 7 0.0000
335 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
336 NASOPHARYNGITIS 3 0.0000
337 VISUAL IMPAIRMENT 2 0.0000
338 RHINORRHOEA 1 0.0000
339 PNEUMONIA 5 0.0000
340 AMNESIA 1 0.0000
341 BLOOD PRESSURE DECREASED 1 0.0000
342 VISION BLURRED 2 0.0000
343 COUGH 4 0.0000
344 HYPOAESTHESIA 2 0.0000
345 HALLUCINATION 1 0.0000
346 ACUTE KIDNEY INJURY 2 0.0000
347 CARDIAC FAILURE CONGESTIVE 1 0.0000
348 INFLUENZA LIKE ILLNESS 1 0.0000
349 BALANCE DISORDER 1 0.0000
350 RASH 5 0.0000
351 MUSCULOSKELETAL STIFFNESS 1 0.0000
352 PAIN 7 0.0000
353 TACHYCARDIA 1 0.0000
354 MUSCLE SPASMS 2 0.0000
355 OROPHARYNGEAL PAIN 1 0.0000
356 CARDIAC DISORDER 1 0.0000
357 DYSPHAGIA 1 0.0000
358 PULMONARY EMBOLISM 1 0.0000
359 MIGRAINE 1 0.0000
360 PRURITUS 4 0.0000
361 HEART RATE INCREASED 1 0.0000
362 SYNCOPE 1 0.0000
363 SINUSITIS 1 0.0000
364 PLATELET COUNT DECREASED 1 0.0000
365 OVERDOSE 2 0.0000
366 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
367 PALPITATIONS 1 0.0000
368 DIZZINESS 4 0.0000
369 DRUG INEFFECTIVE 10 0.0000
370 RENAL FAILURE 1 0.0000
371 MALAISE 3 0.0000
372 PRODUCT DOSE OMISSION ISSUE 2 0.0000
373 CONDITION AGGRAVATED 2 0.0000
374 DRUG INTERACTION 1 0.0000
375 CONFUSIONAL STATE 1 0.0000
376 FALL 2 0.0000
377 PYREXIA 2 0.0000
378 MYOCARDIAL INFARCTION 1 0.0000
379 COVID-19 1 0.0000
380 CHEST PAIN 1 0.0000
381 HYPERSENSITIVITY 1 0.0000
382 PRODUCT USE ISSUE 1 0.0000
383 DYSPNOEA 3 0.0000
384 SOMNOLENCE 1 0.0000
385 ANXIETY 1 0.0000
386 HEADACHE 2 0.0000